MP43-11 CHARACTERIZATION OF THE URINARY MICROBIOME IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH BACILLUS CALMETTE-GUéRIN IMMUNOTHERAPY

Randy F. Sweis,Shay Golan,Nimrod Barashi,Elle Hill,Ciro Andolfi,Jeffrey Bloodworth,Ryan Werntz,Gary D. Steinberg

MP43-11 CHARACTERIZATION OF THE URINARY MICROBIOME IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH BACILLUS CALMETTE-GUéRIN IMMUNOTHERAPY

2019

Randy F. Sweis
Shay Golan
Nimrod Barashi
Elle Hill
Ciro Andolfi
Jeffrey Bloodworth
Ryan Werntz
Gary D. Steinberg

INTRODUCTION AND OBJECTIVES:Bacillus Calmette-Guerin (BCG) therapy is effective at preventing recurrence in many patients with high-risk, non-muscle invasive bladder cancer (NMIBC). Despite its eff...

Keywords:

Microbiome
Urology
Immunotherapy
Bladder cancer
Urinary system
Medicine
in patient
non muscle invasive

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations